Global Poliomyelitis Market, By Type (Nonparalytic Polio, Nonparalytic Polio, Post-Polio Syndrome), Treatment (Medication, Vaccination, Supportive Treatments, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029.
Poliomyelitis Market Analysis and Size
The global poliomyelitis market is expected to witness significant growth during the forecast period. Rising awareness of poliomyelitis vaccination, continuous clinical studies that are currently under process to treat poliomyelitis infection and procurement of vaccine by WHO, UNICEF and other government authorities to treat poliomyelitis infection will increase the poliomyelitis market.. In addition to this, advances in the treatment options and the presence of well-established healthcare facilities are some of the major impacting factors that are available for the demand of poliomyelitis market. COVID-19 also had a major impact on the market growth.
Data Bridge Market Research analyses a growth rate in the global poliomyelitis market in the forecast period 2022-2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
Poliomyelitis is a highly infectious viral disease wherein the poliovirus invades in the nervous system of human beings which causes serious life threating disabilities and irreversible paralysis in a matter of hours. This virus spread through person to person contact. When a person is infected with the polio, the virus enters into the body via mouth and gets multipled in the intestine. Then, the virus sheds in environment through faeces and from there it can spread rapidly to community especially in poor hygiene and sanitation area.
Poliomyelitis Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Nonparalytic Polio, Nonparalytic Polio, Post-Polio Syndrome), Treatment (Medication, Vaccination, Supportive Treatments, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Pfizer Inc. (U.S.), GSK plc (U.K.), Novartis AG (Switzerland), Mylan N.V. (U.S.), Sanofi (France), Boehringer Ingelheim International GmbH. (Germany), Merck & Co., Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Bristol-Myers Squibb Company (U.S.), Astellas Pharma Inc. (Japan)
|
|
Market Opportunities
|
|
Global Poliomyelitis Market Dynamics
Drivers
- Rising Awareness
In the last few years, government and non-government organizations in developing countries, have taken extreme efforts to raise awareness for preventive medicine. Several programs are conducted that reach out to uneducated people especially in rural areas. For instance, Polio eradication strategy 2022-2026 was launched by GPEI in the year 2020 has maintained a special goal for eradicating remaining type of WPV1 and validating the absence of cVDPV2 and also preparing for post-polio challenges. This is a key factor that boosts the Bacterial Vaccines Market in the world's emerging economies.
- Rising Demand for Oral Drugs
Oral drugs is expected to boost the market growth. The segment is expected to accelerate the global market as most products are available in capsule and tablet form and it is a very feasible route of administration.
Opportunities
- Increasing Demand for Retail Pharmacies
Rise in the number of poliomyelitis therapeutics being delivered through retail pharmacies and surge in the number of retail pharmacies in developed countries create opportunities for the market growth. In addition to this, patients prefer retail pharmacies for purchasing drugs, as these are easily accessible.
- Growing Demand of Poliomyelitis Vaccination
The world population had a count of 7.9 billion in 2021, which needs to be prevented from polio virus and many other viruses. As per many studies, 179.8 thousand of the child birth was recorded in the year 2021. The world has achieved 99% reduction from the polio virus transmission and elimination of 5 out of 6 regions which comes under WHO. This boosts the market growth.
Restraints/Challenges
- Lack of skilled professionals
The lack of qualified personnel who are unable to treat the patients with appropriate treatments could curb the growth of the global poliomyelitis market over a forecast period.
- Side Effects of Bacterial Vaccines
There are many side effects associated with poliomyelitis vaccines that surely hamper the market growth. Side effects such as fever, chills, enduration, pain and soreness, and many such effects restrain the growth of the market.
This global poliomyelitis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global poliomyelitis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Impact of COVID-19 on Global Poliomyelitis Market
With the onset of COVID-19 pandemic, its vaccine development increased to a great extent. It hampered the poliomyelitis market. The market faced a bit of setback during the pandemic. But in the post pandemic era, as the cases were decreasing and the focus was shifting towards the other diseases and vaccine development, the poliomyelitis faced a highrise and its expected to witness a huge growth in the coming years.
Global Poliomyelitis Market Scope
The global poliomyelitis market is segmented on the basis of type, treatment, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Nonparalytic Polio
- Nonparalytic Polio
- Post-Polio Syndrome
Treatment
- Medication
- Vaccination
- Supportive Treatments
- Others
Route of Administration
- Oral
- Parenteral
- Others
End User
- Hospitals
- Homecare
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Poliomyelitis Market Regional Analysis/Insights
The global poliomyelitis market is analysed and market size insights and trends are provided by type, treatment, route of administration, distribution channel and end-user as referenced above.
The major countries covered in the global poliomyelitis market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America has been witnessing a positive growth for global poliomyelitis market throughout the forecasted period due to increased healthcare expenditure and government focus towards providing reliable healthcare solution.
Asia-Pacific dominates the market due to increased healthcare expenditure and government focus towards providing reliable healthcare solution.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Poliomyelitis Market Share Analysis
The global poliomyelitis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global poliomyelitis market.
Key players operating in the global poliomyelitis market include:
- Pfizer Inc. (U.S.)
- GSK plc (U.K.)
- Novartis AG (Switzerland)
- Mylan N.V. (U.S.)
- Sanofi (France)
- Boehringer Ingelheim International GmbH. (Germany)
- Merck & Co., Inc. (U.S.)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Bristol-Myers Squibb Company (U.S.)
- Astellas Pharma Inc. (Japan)
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.
The key
SKU-